Skip to main content
No. of Recommendations: 1
Something changed since then?

----

CRSP looks like it just about tripled. :)
EDIT up maybe 50%, NTLA appears flat.


Heard a very interesting podcast over the Winter with CRISP expert:
https://samharris.org/podcasts/humanity-2-0/

MIT article in Dec:
https://www.technologyreview.com/s/609722/crispr-in-2018-com...

Science mag in Dec:
https://www.sciencedaily.com/releases/2017/12/171207141735.h...

Since then - more recent stuff

March - making mosquitos malaria-resistant:
https://www.sciencedaily.com/releases/2018/03/180308143052.h...

CRISPR can cut RNA too (not just DNA):
https://www.sciencedaily.com/releases/2018/03/180301144150.h...
The ability to target RNA instead of DNA expands how Cas9 scissors can be used. Potential uses range from controlling which genes are turned off or on to combatting human viruses that are made of RNA to rapidly detecting infectious agents.

CRISPR-edited crops:
https://www.the-scientist.com/?articles.view/articleNo/52209...
In a statement released on March 28 the USDA stated that they will not regulate plants that have been modified through genome editing as long as the same genotype could have been produced through traditional breeding methods. This announcement has the potential to shave tens of millions of dollars off the cost of crop develop.


apparently a study was done that sent CRISPR stocks plummeting. And then it was retracted.
A sign of FUD hitting the market could possibly be (ironically) an indicator that there is something real about the TAM of the market.
https://www.wired.com/story/a-flawed-study-shows-how-little-...
It was an overreaction, as so many market spikes and dips turn out to be; the company CEOs were quick to push back, and scientists and journalists soon pointed out flaws in the paper that misconstrued cause and effect. After nearly a year of continued criticisms, and failures to reproduce the results, the authors conceded that the skeptics might be right. Last week, the journal that published the paper, Nature Methods, finally retracted it.

Some ex SpaceX employees starting up their own biotech to leverage CRISPR:
https://www.cnbc.com/2018/04/19/synthego-helping-scientists-...

and it looks like human trials starting:
https://www.technologyreview.com/s/610721/crispr-trials-are-...
"Soylent green is people...it's people!" - nothing to do with this article, just love that movie line.

-Dreamer
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.